The global apoptosis regulator BAX market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Apoptosis regulator BAX is also known as BCL-2-like protein 4. It is a protein that is encoded by the BAX gene in humans. Additionally, BAX is a member of the Bcl-2 gene family which form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The major factor driving the market growth is the increasing prevalence of liver cancer across the globe.
According to the American Cancer Society, in 2022, liver cancer is a leading cause of mortality each year globally. Additionally, an estimated 41,260 new cases will be diagnosed with liver cancer in the US. Out of which 28,600 cases will be diagnosed in men and 12,660 will be diagnosed in women. Furthermore, more than 800,000 people are diagnosed with liver cancer each year across the globe. Moreover, BAX is a central cell death regulator and a core regulator of the intrinsic pathway of apoptosis. Additionally, it controls apoptosis in normal and cancer cells. Hence, the increasing prevalence of liver cancer is driving the demand for apoptosis regulator BAX.
To Request a Sample of our Report on Apoptosis Regulator BAX Market: https://www.omrglobal.com/request-sample/apoptosis-regulator-bax-market
Some major players in the market include Genervon Biopharmaceuticals LLC, Lytix Biopharma AS, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, Ipsen has signed an exclusive global collaboration agreement with BAKX Therapeutics Inc. The collaboration was aimed to research, develop, manufacture and commercialize BKX-001 as a potential treatment for leukemia, lymphoma and solid tumors.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Genervon Biopharmaceuticals LLC, and Lytix Biopharma AS, among others.
A full Report of Apoptosis Regulator BAX Market is Available @ https://www.omrglobal.com/industry-reports/apoptosis-regulator-bax-market
Global Apoptosis Regulator BAX Market Report by Segment
By Type
- GM-6
- HU-010
- LTX-401
- Others
By Application
- Liver Cancer
- Melanoma
- Stroke
- Parkinson’s Disease
- Others
Global Apoptosis Regulator BAX Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
